High cost of ED treatment for ADRs in elderly

September 2012
Reactions Weekly;9/15/2012, Issue 1419, p3
The article reports on a study which found that emergency department (ED) visits by elderly patients for adverse drug reactions (ADR) creates a significant and increasing economic burden.


Related Articles

  • Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments. Chen Wu; Bell, Chaim M.; Wodchis, Walter P. // Drug Safety;2012, Vol. 35 Issue 9, p769 

    Background: The rapid rise in the availability and use of pharmaceutical agents, and particularly polypharmacy, directly increases the risk for patients to experience adverse drug reactions (ADRs). There are few studies on the overall incidence and costs of ADRs. Objective: The aim of this study...

  • Drug-related ED visits costly, often due to ADRs.  // PharmacoEconomics & Outcomes News;2/11/2006, Issue 496, p7 

    The article discusses research being done on the costs associated with adverse drug reactions (ADRs). It references a study by J. L. Yee, N. K. Hasson and D. H. Schreiber in the December 2005 issue of "Annals of Pharmacotherapy." Using the Naranjo probability scale, the proponents noted that...

  • Insulin-related hypoglycaemia common cause of ED visits.  // Reactions Weekly;Apr2014, Vol. 1496 Issue 1, p3 

    The article reports that according to a study published in "JAMA Internal Medicine," insulin-related hypoglycaemia and errors (IHEs) are the main causes of emergency-department (ED) visits and hospitalisations for adverse drug events (ADEs) in the U.S.

  • ADR costs in India "significant.".  // PharmacoEconomics & Outcomes News;5/28/2011, Issue 629, p4 

    The article discusses research on the cost of adverse drug reactions in India, referencing a study by T. Rajakannan and colleagues published in the April 2011 issue of the "Journal of Clinical Pharmacology."

  • Alemtuzumab-related neutropenia ups costs in renal transplantation.  // Reactions Weekly;6/19/2010, Issue 1306, p4 

    The article discusses a research study on the clinical and financial implications of alemtuzumab-related neutropenia in kidney transplant patients, presented at the 10th Joint Congress of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST).

  • ADE alert saves costs, reduces severity-adjusted mortality.  // Reactions Weekly;5/15/2010, Issue 1301, p3 

    This article discusses a study on the effectiveness of an adverse drug event (ADE) alert system in reducing pharmacy department costs and variable drug costs at community hospitals in the U.S.

  • Should we charge for A&E? Gibney, Daniel R. // British Journal of General Practice;Aug2013, Vol. 63 Issue 613, p402 

    A letter to the editor about charges for treatment provided by general practitioners (GPs) for accident and emergency (A&E) cases in Great Britain is presented.

  • Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. Reithinger, Richard; Coleman, Paul G. // BMC Infectious Diseases;2007, Vol. 7 Issue 1, p3 

    Background: Although Kabul city, Afghanistan, is currently the worldwide largest focus of cutaneous leishmaniasis (CL) with an estimated 67,500 cases, donor interest in CL has been comparatively poor because the disease is non-fatal. Since 1998 HealthNet TPO (HNTPO) has implemented...

  • Study: ED asthma patients get needless antibiotics.  // ED Nursing;Nov2008, Vol. 12 Issue 1, p10 

    The article highlights the results of a study which reveal that acute asthma patients often are given unnecessary antibiotics in the emergency department. The study found that about 20 percent of acute asthma visits resulted in an antibiotic prescription. The study used data from the National...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics